Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo
about
The Janus-Faced Role of Antioxidants in Cancer Cachexia: New Insights on the Established ConceptsSplicing of the rSlo gene affects the molecular composition and drug response of Ca2+-activated K+ channels in skeletal muscleConcurrent evolution of cancer cachexia and heart failure: bilateral effects exist.Both aerobic exercise and resveratrol supplementation attenuate doxorubicin-induced cardiac injury in mice.C26 cancer-induced muscle wasting is IKKβ-dependent and NF-kappaB-independent.Ubiquinol reduces muscle wasting but not fatigue in tumor-bearing miceResearch on cachexia, sarcopenia and skeletal muscle in cardiology.Spontaneous Physical Activity Downregulates Pax7 in Cancer CachexiaMetabolic derangements in the gastrocnemius and the effect of Compound A therapy in a murine model of cancer cachexiaNuclear factor-κB signalling and transcriptional regulation in skeletal muscle atrophy.Cancer cachexia update in head and neck cancer: Definitions and diagnostic features.F-BOX proteins in cancer cachexia and muscle wasting: Emerging regulators and therapeutic opportunities.Prevention of liver cancer cachexia-induced cardiac wasting and heart failure.Pay attention to cardiac remodeling in cancer cachexia.Baicalin, a component of Scutellaria baicalensis, alleviates anorexia and inhibits skeletal muscle atrophy in experimental cancer cachexia.Resveratrol-mediated apoptosis of hodgkin lymphoma cells involves SIRT1 inhibition and FOXO3a hyperacetylation.Resveratrol prevents dexamethasone-induced expression of the muscle atrophy-related ubiquitin ligases atrogin-1 and MuRF1 in cultured myotubes through a SIRT1-dependent mechanism.Post-translationally modified muscle-specific ubiquitin ligases as circulating biomarkers in experimental cancer cachexia.Dietary supplementation with shiikuwasha extract attenuates dexamethasone-induced skeletal muscle atrophy in aged ratsCanadine from Corydalis turtschaninovii Stimulates Myoblast Differentiation and Protects against Myotube Atrophy.Effects of resveratrol supplementation on risk factors of non-communicable diseases: A meta-analysis of randomized controlled trials.Resveratrol attenuates denervation-induced muscle atrophy due to the blockade of atrogin-1 and p62 accumulation.Resveratrol Improves Muscle Atrophy by Modulating Mitochondrial Quality Control in STZ-Induced Diabetic Mice.Physiological culture conditions alter myotube morphology and responses to atrophy treatments: implications for in vitro research on muscle wasting.
P2860
Q28078802-27889D4A-83C3-43AB-8E25-726EC56BABD8Q28481241-CF05518B-E517-4FB0-B808-2CAB752A8954Q33741091-9212C410-4E18-4FBC-A1B4-FC3F7D270FB2Q33976440-69E959E8-EAC8-4107-A445-01C8884A298DQ35086723-32688CA2-0D77-4610-A1BF-B83F0F4D7D78Q35186185-967E2EDF-E538-4533-93DE-A294A73B0E71Q36421043-1345FAF4-5D4A-4738-A652-DFBDF7F07929Q36726861-2E59341F-3EE8-44CA-AA63-3CB6B75BA13BQ36934990-E5DF2409-B82E-40A2-B2FD-2DCBF5DE9F97Q38030905-2C229913-C47B-4A2A-8C7C-EB9925FFB856Q38177750-1EEB0102-4D5A-4A63-BF42-D679A2B07F74Q38577674-350A17E4-80DD-461D-BDC2-D6F6DF6E9862Q38628641-9EBD128F-20B1-4063-8E79-5C807063EB30Q38815915-E6E8FFFD-88F4-4D80-AE99-C2D56EC80887Q38959117-F1A53574-A4B4-4F20-B0B6-CB8795987018Q39308056-8DAAF121-DF6C-431E-93B3-06AC4C45150BQ39429075-2D1AF8B6-F6EE-416F-A80F-A9240F138C69Q42033093-7F237CA5-25F8-411A-ABAA-093D99D94E44Q42084239-0B7F6683-3829-4002-A63B-6A5B5A1E0F2DQ47274750-6D3F9A39-E9B5-4CCE-BA23-3D22D5F36910Q47768938-5E21208F-1CDA-4FB0-8EB1-243D0C67AB38Q55152586-3E939433-80AD-4AE1-9C9B-DC4829BD7DCAQ55266104-48B13361-3BA6-4802-B6A8-6C63E6787E2CQ55364177-01116852-7D27-4A1A-AB14-20F46A1FE6BA
P2860
Oral resveratrol therapy inhibits cancer-induced skeletal muscle and cardiac atrophy in vivo
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Oral resveratrol therapy inhib ...... le and cardiac atrophy in vivo
@ast
Oral resveratrol therapy inhib ...... le and cardiac atrophy in vivo
@en
type
label
Oral resveratrol therapy inhib ...... le and cardiac atrophy in vivo
@ast
Oral resveratrol therapy inhib ...... le and cardiac atrophy in vivo
@en
prefLabel
Oral resveratrol therapy inhib ...... le and cardiac atrophy in vivo
@ast
Oral resveratrol therapy inhib ...... le and cardiac atrophy in vivo
@en
P2093
P2860
P1433
P1476
Oral resveratrol therapy inhib ...... le and cardiac atrophy in vivo
@en
P2093
Denis C Guttridge
Jessica E Rodríguez
Kibwei A McKinney
Lisa J Weinstein
Marion E Couch
Monte Willis
Scott Shadfar
Xiaoying Yin
P2860
P304
P356
10.1080/01635581.2011.563032
P577
2011-06-09T00:00:00Z